Melatonin Eql Pharma (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the suprachiasmatic nucleus, the brain’s master clock. This mimics the natural rise in endogenous melatonin that occurs at night, signalling darkness to the body, reducing sleep latency and helping to align the circadian rhythm with the desired sleep‑wake schedule.

The appropriate dose of Melatonin Eql Pharma is determined by the prescribing healthcare professional based on the individual’s age, condition being treated, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for melatonin use during pregnancy and lactation are limited. Healthcare providers usually recommend avoiding routine use unless the potential benefit outweighs any possible risk. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Melatonin Eql Pharma. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike sedative hypnotics that depress central nervous system activity, melatonin acts on specific MT1/MT2 receptors to regulate the circadian clock, resulting in a more physiological promotion of sleep. It generally has a lower risk of dependence and fewer cognitive side effects, but its efficacy may be modest for severe insomnia compared with prescription hypnotics.

Store Melatonin Eql Pharma at temperatures below 25 °C, in its original container, protected from moisture, heat and direct light. Keep the product out of reach of children and avoid exposing it to excessive humidity, which could affect tablet integrity.

Melatonin Eql Pharma is taken orally, typically with a glass of water. It is usually administered shortly before the desired bedtime, allowing the active ingredient to coincide with the body’s natural night‑time melatonin surge. Patients should follow the dosing instructions provided by their prescriber.

Serious but rare risks include severe allergic reactions such as rash, swelling or anaphylaxis, marked dizziness or fainting, and rare neuropsychiatric events like hallucinations or profound mood changes. Any sudden or severe reaction should prompt immediate medical evaluation.

Individuals with known hypersensitivity to melatonin or any excipients in the product should avoid it. It is also contraindicated in patients taking monoamine oxidase inhibitors or those with uncontrolled severe hepatic impairment without medical supervision. Children should only use melatonin under pediatric guidance.